Who are recombinant gonadotropins's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): r-FSH plus HP-hMG, Placebo, gonadotropins in step-up regimen, High dose gonadotropins, ovarian stimulation, Orgovyx, Orilissa.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/recombinant-gonadotropins.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

recombinant gonadotropins — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

recombinant gonadotropins (recombinant gonadotropins) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Medicine / Fertility.

marketed Gonadotropin FSH receptor, LH receptor Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

recombinant gonadotropins (recombinant gonadotropins) — Sheba Medical Center. Recombinant gonadotropins are hormones that stimulate the ovaries or testes to produce eggs or sperm for reproductive purposes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
recombinant gonadotropins TARGET	recombinant gonadotropins	Sheba Medical Center	marketed	Gonadotropin	FSH receptor, LH receptor
r-FSH plus HP-hMG	r-FSH plus HP-hMG	Instituto Valenciano de Infertilidad, IVI VALENCIA	marketed	Gonadotropin combination	FSH receptor, LH receptor
Placebo, gonadotropins in step-up regimen	Placebo, gonadotropins in step-up regimen	University of Modena and Reggio Emilia	marketed	Gonadotropin	FSH receptor, LH receptor
High dose gonadotropins	High dose gonadotropins	Weill Medical College of Cornell University	marketed	Gonadotropin	FSH receptor, LH receptor
ovarian stimulation	ovarian stimulation	Ain Shams Maternity Hospital	marketed	Gonadotropin	FSH receptor, LH receptor
Orgovyx	relugolix	MYOVANT SCIENCES	marketed	Gonadotropin Releasing Hormone Receptor Antagonist [EPC]	Gonadotropin-releasing hormone receptor	2020-01-01
Orilissa	ELAGOLIX	AbbVie	marketed	Gonadotropin Releasing Hormone Receptor Antagonist	Gonadotropin-releasing hormone receptor	2018-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2036-02-25 — Orgovyx · 10350170 · US
2037-09-29 — Orgovyx · 10449191 · US
2037-09-29 — Orgovyx · 11583526 · US
2037-09-29 — Orgovyx · 11033551 · US
2037-09-29 — Orgovyx · 10786501 · US

Sponsor landscape (Gonadotropin class)

Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
Organon and Co · 3 drugs in this class
Fundación Santiago Dexeus Font · 3 drugs in this class
Merck KGaA · 2 drugs in this class
Nina la Cour Freiesleben · 2 drugs in this class
IVI Madrid · 2 drugs in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). recombinant gonadotropins — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-gonadotropins. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing